Monoon longifolium
Monoon longifolium · Accepted scientific name
Scientific literature: Very Sparse (21 studies) · ★☆☆☆☆
Monoon longifolium is a versatile plant species characterized by its significant therapeutic potential across various biological activities. Research focusing on its leaves, stems, and fruits has revealed potent cytotoxic, anticancer, antiglycation, and antimicrobial properties. These medicinal effects are largely driven by bioactive chemical constituents such as flavonoids, kolavenic acid, saponins, and tannins found within its extracts. Laboratory studies utilizing ethanolic and methanol extracts have demonstrated effectiveness against HeLa cells through the induction of apoptosis, as well as combatting Methicillin-Resistant Staphylococcus aureus (MRSA). Consequently, this plant serves as a rich source of natural compounds for developing new pharmacological treatments.
- Synonyms
- Polyalthia Longifolia · Unona Longifolia · 1 more
- Common names
- Not available
- Family
- Annonaceae
- Distribution
- Northern America
- Plant Parts
- Leaf · Stem
Classification
Common Names
Monoon longifolium is a versatile botanical species known by a diverse array of regional and common names. In various parts of the world, it is frequently referred to as the Assathi or the Devadara. It is also widely recognized as the False Ashoka Tree, a name that highlights its striking resemblance to other ornamental species. Depending on the local dialect, you may also encounter it called Glodogan Tiang or I-petta. These multiple identities reflect the plant's widespread presence and cultural significance across different landscapes.
Sources: Catalogue of Life (COL)
Synonyms
Monoon longifolium is a botanical species that has been identified by several different scientific names throughout history. Depending on the taxonomic classification used, this plant is also recognized by the synonyms Guatteria longifolia and Polyalthia longifolia. Researchers have also documented it under the names Unona longifolia and Uvaria longifolia in various studies. These varying designations reflect the evolving nature of botanical nomenclature and plant relationships. Understanding these synonyms is essential for ensuring accuracy in scientific communication and plant identification.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Monoon longifolium is a fascinating botanical specimen belonging to the kingdom Plantae. As a member of the genus Monoon, this plant is specifically categorized within the family Annonaceae. It is further classified under the order Magnoliales, reflecting its unique evolutionary lineage. Within the broader biological hierarchy, it is recognized as part of the class Equisetopsida. Understanding these taxonomic relationships provides essential insight into the plant's natural identity and scientific placement.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Magnoliales |
| Family | Annonaceae |
| Genus | Monoon |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Monoon longifolium is a versatile species that maintains a broad geographic presence across several distinct regions. In Africa, its distribution extends through West-Central Tropical Africa, with specific occurrences noted in Cameroon. The plant also thrives across various parts of Asia, including the temperate landscapes of China, specifically within South-Central regions and on the island of Hainan. Its reach continues through Eastern Asia into Taiwan, demonstrating a significant presence in those areas. Furthermore, it is found within the tropical climates of the Indian Subcontinent, particularly in Assam.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Monoon longifolium is a self-supporting plant characterized by its distinct tree-like growth form. This species reaches a maximum height of 15 meters as it matures in its natural habitat. Its sturdy structure allows it to stand firmly within diverse forest ecosystems.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Monoon longifolium, also known as Polyalthia longifolia, demonstrates a diverse range of therapeutic properties that highlight its significant medicinal value. Research indicates that the plant possesses potent anticancer and cytotoxic activities, specifically showing efficacy against various human cancer cell lines such as cervical, lung, and colon carcinoma. Its bioactive compounds also exhibit strong antimicrobial effects, which can even work synergistically with antibiotics to combat resistant bacteria like MRSA. Furthermore, the plant provides critical antioxidant protection and demonstrates antiglycation activity, making it a promising candidate for managing diabetes-related complications. These multifaceted biological activities underscore the potential of Monoon longifolium as a rich source for developing novel herbal drugs.
Compounds
Monoon longifolium, also known as Polyalthia longifolia, serves as a rich source of diverse bioactive compounds with significant therapeutic potential. Chemical analyses of the plant have confirmed that it contains kolavenic acid, which has demonstrated notable cytotoxic and apoptotic properties. Furthermore, the presence of anandamide within its extracts contributes to its complex pharmacological profile. The plant is also characterized by a variety of phenolic compounds, specifically including epicatechin and gallic acid. Additionally, the abundance of flavonoids in Monoon longifolium provides essential antiglycation and antioxidant benefits that support its traditional use in treating metabolic complications.
Conditions
Monoon longifolium, also referred to in research as Polyalthia longifolia, demonstrates significant therapeutic potential by treating MRSA through synergistic antimicrobial activity with antibiotics. The plant's extracts also effectively treat HeLa cells by inducing cytotoxicity and regulating specific microRNAs to combat cancer. Furthermore, the plant treats apoptosis by modulating pro-apoptotic proteins and mitochondrial membrane potential to induce programmed cell death. It also treats AGE fluorescence intensity by inhibiting the formation of advanced glycation end products in fructose-induced systems. Ultimately, these properties allow the plant to treat AGE-mediated diabetic complications by preventing protein glycation and oxidation.
Preparations
Monoon longifolium is prepared as an ethanolic extract to facilitate the bioassay-guided fractionation and isolation of various bioactive clerodane diterpenes. The plant is also prepared as leaves, which serve as the source for both cytotoxic compounds and antioxidant principles. Various methanol extracts are prepared from the stems, twigs, and leaves to identify antifungal and antiproliferative substances. Additionally, the plant is prepared as extracts using different organic solvents to study their ability to inhibit molecular interactions in medicinal research. Finally, Monoon longifolium is prepared as 16-Hydroxy-cleroda-3,13-dien-16,15-olide, a specific compound utilized in advanced nanoparticle delivery systems for anti-glioma treatment.
Parts used
Monoon longifolium, often referred to in scientific literature as Polyalthia longifolia, is a versatile medicinal plant that offers significant therapeutic potential through its various biological components. Research has extensively utilized the plant's leaves to investigate antimicrobial properties and protective effects against oxidative DNA damage. Additionally, the stem serves as a valuable source of bioactive compounds, including various phenolic compounds and flavonoids that exhibit antidiabetic activities. The fruit of the species, observed in both ripe and unripe berry forms, has also been studied for the isolation of cytotoxic clerodane-type diterpenoids. Together, these different parts of the plant highlight its importance in traditional medicine and modern pharmacological exploration.